Navigation Links
Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival
Date:1/12/2012

PHILADELPHIAJefferson's Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind multimodality approach could improve disease control and eventually survival for locally advanced prostate cancer patients.

The single-center, open-label, non-randomized Phase I study of weekly Cabazitaxel with concurrent intensity modulated radiation therapy (IMRT) and androgen deprivation therapy will test its safety and the tolerable maximum dosing.

Cabazitaxel was approved in the U.S. for second-line use in advanced hormone-refractory prostate cancer in men in 2010, and has been described as a major advance in chemotherapy for advanced prostate cancer. It extended overall survival by 2.4 months when compared with mitoxantrone in patients who were previously treated with docetaxel. However, a multimodality approach with the drug has never been studied.

"We know the drug is effective in prostate cancer, but there is no study with radiation and hormone therapy yet," said principal investigator Jianqing Lin, M.D., an assistant professor of medical oncology at Thomas Jefferson University Hospital. "Concurrent radiation may have a better control for localized disease, and better long-term survival for these high-risk patients."

IMRT is a type of 3-dimensional radiation therapy that uses computer-generated images to show the size and shape of the tumor; androgen deprivation therapy is a treatment to suppress or block the production or action of male hormones. Enrolled men will receive weekly treatments of the chemotherapy drug and hormone therapy and then every three months until two years after completion of IMRT.

For the clinical trial, Dr. Lin is partnering with co-investigator Timothy Showalter, M.D., an assistant professor in the Department of Radiation Oncology at Thomas Jefferson University Hospital.


'/>"/>

Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert  

Related medicine news :

1. Experts offer pointers for optimizing radiation dose in pediatric CT
2. Breast Cancer Radiation Linked to Raised Heart Risk
3. Targeted Radiation for Breast Cancer May Be Overused: Study
4. Scientists may be able to double efficacy of radiation therapy
5. Childhood cancer survivors exposure to chemotherapy, radiation does not increase risk of birth defects in their children
6. Blue light irradiation promotes growth, increases antioxidants in lettuce seedlings
7. Radiation May Also Lead to Chemo Brain
8. Targeted Radiation May Not Be Better for Breast Cancer
9. Study finds side effects, complications, mastectomy more likely after partial breast irradiation
10. Cancer cells DNA repair disrupted to increase radiation sensitivity
11. Dana-Farber/Childrens Hospital Boston study identifies possible therapy for radiation sickness
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival
(Date:3/23/2017)... ... March 23, 2017 , ... ... Convention Center at 10 North Broadway Avenue, will be an educational and exciting ... practical instruction in the management of chronic pain. , Oklahoma is in a ...
(Date:3/23/2017)... New Holland, PA and Grimsby, Ontario (PRWEB) , ... March 23, 2017 , ... The ... to the modular industry or whose acts have had a significant impact on the careers ... of Sales and Marketing with NRB Inc. was inducted into the MBI’s Hall of Fame. ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... businesses of the Norwalk and Vermillion areas, celebrates the newest charity campaign ... a nonprofit, community-based substance abuse prevention and peer recovery support organization providing ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits delivery trailblazer, ... mobile app and centralized benefits dashboard solving one of the top frustrations in ... locations. For the first time, employees can access up-to-date information and account balances ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Angeles based healthcare technology company California Healthcom Group (CHG). , The HUG ... healthcare arena. With headquarters in California, CHG is a growing, internationally recognized healthcare ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  The goal of the pilot ... and track prescription drugs as they are distributed in ... to requirements from US FDA to better protect consumers ... medicines. Blockchain startup Chronicled, which links ... and blockchain technology and recently raised $6.25M, and the ...
(Date:3/23/2017)... /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or ... announces that AB Laboratories Inc. ("AB Labs") has successfully ... under the Access to Cannabis for Medical Purposes Regulations ... The facility, which was licensed for ... operating at half capacity, with full production capacity scheduled ...
(Date:3/23/2017)... N.J. , March 23, 2017 /PRNewswire/ ... company, announced a major milestone today.  Following ... with the U.S. Food and Drug Administration ... clear clinical and regulatory path forward to ... CPI-613, in patients with acute myeloid leukemia ...
Breaking Medicine Technology: